Subclinical hypercortisolism in adrenal incidentaloma

Bovio, 2006, Prevalence of adrenal incidentaloma in a contemporary computerized tomography series., J Endocrinol Invest, 29, 298, 10.1007/BF03344099

Kloos, 1995, Incidentally discovered adrenal masses., Endocr Rev, 16, 460

Kim, 2013, Clinical characteristics for 348 patients with adrenal incidentaloma., Endocrinol Metab (Seoul), 28, 20, 10.3803/EnM.2013.28.1.20

Mansmann, 2004, The clinically inapparent adrenal mass: update in diagnosis and management., Endocr Rev, 25, 309, 10.1210/er.2002-0031

Barzon, 2003, Prevalence and natural history of adrenal incidentalomas., Eur J Endocrinol, 149, 273, 10.1530/eje.0.1490273

Chiodini, 2011, Clinical review: diagnosis and treatment of subclinical hypercortisolism., J Clin Endocrinol Metab, 96, 1223, 10.1210/jc.2010-2722

Di Dalmazi, 2014, Cardiovascular events and mortality in patients with adrenal incidentalomas that are either nonsecreting or associated with intermediate phenotype or subclinical Cushings syndrome: a 15-year retrospective study., Lancet Diabetes Endocrinol, 2, 396, 10.1016/S2213-8587(13)70211-0

Di Dalmazi, 2012, Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study., Eur J Endocrinol, 166, 669, 10.1530/EJE-11-1039

Debono, 2014, Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas., J Clin Endocrinol Metab, 99, 4462, 10.1210/jc.2014-3007

Tauchmanova, 2002, Patients with subclinical Cushings syndrome due to adrenal adenoma have increased cardiovascular risk., J Clin Endocrinol Metab, 87, 4872, 10.1210/jc.2001-011766

Debono, 2013, Visceral fat accumulation and postdexamethasone serum cortisol levels in patients with adrenal incidentaloma., J Clin Endocrinol Metab, 98, 2383, 10.1210/jc.2012-4276

Nieman, 2008, The diagnosis of Cushings syndrome: an Endocrine Society Clinical Practice Guideline., J Clin Endocrinol Metab, 93, 1526, 10.1210/jc.2008-0125

Terzolo, 2011, AME position statement on adrenal incidentaloma., Eur J Endocrinol, 164, 851, 10.1530/EJE-10-1147

Sereg, 2009, Atherosclerotic risk factors and complications in patients with nonfunctioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study., Eur J Endocrinol, 160, 647, 10.1530/EJE-08-0707

Toniato, 2009, Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study., Ann Surg, 249, 388, 10.1097/SLA.0b013e31819a47d2

Cawood, 2009, Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink Eur J E, ndocrinol, 161, 513

Vassilatou, 2014, Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications., Eur J Endocrinol, 171, 37, 10.1530/EJE-13-0848

Olsen, 2012, Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden., Endocrine, 42, 164, 10.1007/s12020-012-9622-2

Morelli, 2014, Long-term follow-up in adrenal incidentalomas: an Italian Multicenter Study., J Clin Endocrinol Metab, 99, 827, 10.1210/jc.2013-3527

Stewart, 2010, Is subclinical Cushings syndrome an entity or a statistical fallout from diagnostic testing Consensus surrounding the diagnosis is required before optimal treatment can be defined., J Clin Endocrinol Metab, 95, 2618, 10.1210/jc.2010-0633

Young, 2007, Clinical practice. The incidentally discovered adrenal mass., N Engl J Med, 356, 601, 10.1056/NEJMcp065470

Reimondo, 2011, Pros and cons of dexamethasone suppression test for screening of subclinical Cushings syndrome in patients with adrenal incidentalomas., J Endocrinol Invest, 34, e1, 10.1007/BF03346701

Eller-Vainicher, 2010, Accuracy of several parameters of hypothalamic-pituitary-adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma., Eur J Endocrinol, 163, 925, 10.1530/EJE-10-0602

Eller-Vainicher, 2010, Postsurgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery Eur J E, ndocrinol, 162, 91

Morelli, 2010, Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects., Clin Endocrinol (Oxf), 73, 161, 10.1111/j.1365-2265.2010.03794.x

Ceccato, 2013, Performance of salivary cortisol in the diagnosis of Cushings syndrome, adrenal incidentaloma and adrenal insufficiency., Eur J Endocrinol, 169, 31, 10.1530/EJE-13-0159

Masserini, 2009, The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma., Eur J Endocrinol, 160, 87, 10.1530/EJE-08-0485

Perogamvros, 2010, Salivary cortisone is a potential biomarker for serum free cortisol., J Clin Endocrinol Metab, 95, 4951, 10.1210/jc.2010-1215

Perogamvros, 2009, Simultaneous measurement of cortisol and cortisone in human saliva using liquid chromatography-tandem mass spectrometry: application in basal and stimulated conditions., J Chromatogr B Analyt Technol Biomed Life Sci, 877, 3771, 10.1016/j.jchromb.2009.09.014

Palmieri, 2013, The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism., Eur J Endocrinol, 168, 289, 10.1530/EJE-12-0803

Di Dalmazi, 2014, Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushings syndrome: a systematic review of the literature., J Clin Endocrinol Metab, 99, 2637, 10.1210/jc.2014-1401

Nieman, 2010, Approach to the patient with an adrenal incidentaloma., J Clin Endocrinol Metab, 95, 4106, 10.1210/jc.2010-0457

Di Dalmazi, 2014, Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushings syndrome: a European multicentric study., J Clin Endocrinol Metab, 99, E2093, 10.1210/jc.2014-2152

Beuschlein, 2014, Constitutive activation of PKA catalytic subunit in adrenal Cushings syndrome., N Engl J Med, 370, 1019, 10.1056/NEJMoa1310359

Giordano, 2012, Glucose metabolism in patients with subclinical Cushings syndrome., Endocrine, 41, 415, 10.1007/s12020-012-9628-9

Mazziotti, 2011, Diabetes in Cushing syndrome: basic and clinical aspects., Trends Endocrinol Metab, 22, 499, 10.1016/j.tem.2011.09.001

Androulakis, 2014, Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion., J Clin Endocrinol Metab, 99, 2754, 10.1210/jc.2013-4064

Chiodini, 2007, Subclinical hypercortisolism among outpatients referred for osteoporosis., Ann Intern Med, 147, 541, 10.7326/0003-4819-147-8-200710160-00006

Morelli, 2011, Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study., J Bone Miner Res, 26, 1816, 10.1002/jbmr.398

Eller-Vainicher, 2012, Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism., J Bone Miner Res, 27, 2223, 10.1002/jbmr.1648

Sereg, 2011, Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushings syndrome., Steroids, 76, 38, 10.1016/j.steroids.2010.08.007

Morelli, 2010, Role of glucocorticoid receptor polymorphism in adrenal incidentalomas., Eur J Clin Invest, 40, 803, 10.1111/j.1365-2362.2010.02330.x

Elamin, 2008, Accuracy of diagnostic tests for Cushings syndrome: a systematic review and metaanalyses., J Clin Endocrinol Metab, 93, 1553, 10.1210/jc.2008-0139

Chiodini, 2010, Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism., J Clin Endocrinol Metab, 95, 2736, 10.1210/jc.2009-2387

Akaza, 2011, Clinical outcome of subclinical Cushings syndrome after surgical and conservative treatment., Hypertens Res, 34, 1111, 10.1038/hr.2011.90

Guerrieri, 2010, Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy A retrospective study with long-term follow-up evaluation., Surg Endosc, 24, 2542, 10.1007/s00464-010-1000-7

Tsuiki, 2008, Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushings syndrome., Endocr J, 55, 737, 10.1507/endocrj.K07E-177

Iacobone, 2012, Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushings syndrome., Surgery, 152, 991, 10.1016/j.surg.2012.08.054

Debono, 2013, Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol: a pilot study., PLoS One, 8, e60984, 10.1371/journal.pone.0060984